Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 25.0 | 90 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 18.0 | 71 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 21.0 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 22.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 21.5 | 52 | |
RA2159 | EO1428 | 1.0 | uM | 1 | CTACK | 22.0 | 77 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | CTACK | 26.5 | 46 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 23.0 | 39 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 20.0 | 37 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 26.0 | 71 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 23.0 | 54 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | CTACK | 26.0 | 33 | |
N2586 | EO1428 | 1.0 | uM | 1 | CTACK | 17.0 | 56 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 24.0 | 75 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 27.0 | 89 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 22.5 | 54 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 22.5 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 22.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 17.5 | 58 | |
RA2159 | PI103 | 0.1 | uM | 1 | CTACK | 23.0 | 58 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 29.0 | 45 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 25.5 | 54 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 27.0 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 28.5 | 72 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 26.0 | 62 |